Effects of angiopoietin-like protein 3 deficiency on postprandial lipid and lipoprotein metabolism
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
The consequences of angiopoietin-like protein 3 (ANGPTL3) deficiency on postprandial lipid and lipoprotein metabolism has not been investigated in humans. We studied 7 homozygous (undetectable circulating ANGPTL3 levels) and 31 heterozygous (50% of circulating ANGPTL3 levels) subjects with familial combined hypolipidemia (FHBL2) due to inactivating ANGPTL3 mutations in comparison with 35 controls. All subjects were evaluated at fasting and during 6 h after a high fat meal. Postprandial lipid and lipoprotein changes were quantified by calculating the areas under the curve (AUCs) using the 6 h concentration data. Plasma changes of β-hydroxybutyric acid (β-HBA) were measured as marker of hepatic oxidation of fatty acids. Compared with controls, homozygotes showed lower incremental AUCs (iAUCs) of total TG (-69%, P < 0.001), TG-rich lipoproteins (-90%, P < 0.001), apoB-48 (-78%, P = 0.032), and larger absolute increase of FFA (128%, P < 00.1). Also, heterozygotes displayed attenuated postprandial lipemia, but the difference was significant only for the iAUC of apoB-48 (-28%; P < 0.05). During the postprandial period, homozygotes, but not heterozygotes, showed a lower increase of β-HBA. Our findings demonstrate that complete ANGPTL3 deficiency associates with highly reduced postprandial lipemia probably due to faster catabolism of intestinally derived lipoproteins, larger expansion of the postprandial FFA pool, and decreased influx of dietary-derived fatty acids into the liver. These results add information on mechanisms underlying hypolipidemia in FHBL2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ANGPTL3 is a genetically validated target for HTG to reduce ASCVD risk.11,77–79”
From Clinical review on triglycerides (2020) · cites this paper as [77]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Loss-of-function variants in ANGPTL3 have been associated with reduced plasma levels of TG, LDL-C, and HDL-C.32,64,65”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619
Bioelectrical impedance analysis—part II: utilization in clinical practice
Kyle, U. G., Bosaeus, I., De Lorenzo, A. D., Deurenberg, P., Elia, M., Manuel Gómez, J., Lilienthal Heitmann, B., Kent-Smith, L., Melchior, J.-C., Pirlich, M., et al. (2004) · Clinical Nutrition · doi:10.1016/j.clnu.2004.09.012 · Cited by 2,350
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871 · cited 1×
“In observational studies, plasma concentrations of TGs in both fasting and fed state are associated with risk of coronary heart disease (1, 2).”
BackgroundSarwar, N., Danesh, J., Eiriksdottir, G., Sigurdsson, G., Wareham, N., Bingham, S., Boekholdt, S. M., Khaw, K.-T., & Gudnason, V. (2007) · Circulation · doi:10.1161/circulationaha.106.637793 · Cited by 1,408 · cited 1×
“In observational studies, plasma concentrations of TGs in both fasting and fed state are associated with risk of coronary heart disease (1, 2).”
BackgroundExome Sequencing, ANGPTL3 Mutations, and Familial Combined Hypolipidemia
Musunuru, K., Pirruccello, J. P., Do, R., Peloso, G. M., Guiducci, C., Sougnez, C., Garimella, K. V., Fisher, S., Abreu, J., Barry, A. J., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002926 · Cited by 754
Lipoprotein lipase: from gene to obesity
Wang, H., & Eckel, R. H. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90920.2008 · Cited by 741
Sun, S. S., Chumlea, W. C., Heymsfield, S. B., Lukaski, H. C., Schoeller, D., Friedl, K., Kuczmarski, R. J., Flegal, K. M., Johnson, C. L., & Hubbard, V. S. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.2.331 · Cited by 692
Physiological regulation of lipoprotein lipase
Kersten, S. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.03.013 · Cited by 550
Indirect Calorimetry: A Practical Guide for Clinicians
Haugen, H. A., Chan, L., & Li, F. (2007) · Nutrition in Clinical Practice · doi:10.1177/0115426507022004377 · Cited by 512
Kersten, S., Mandard, S., Tan, N. S., Escher, P., Metzger, D., Chambon, P., Gonzalez, F. J., Desvergne, B., & Wahli, W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004029200 · Cited by 489
Köster, A., Chao, Y. B., Mosior, M., Ford, A., Gonzalez-DeWhitt, P. A., Hale, J. E., Li, D., Qiu, Y., Fraser, C. C., Yang, D. D., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0476 · Cited by 427
Measurement of energy expenditure
Levine, J. A. (2005) · Public Health Nutrition · doi:10.1079/phn2005800 · Cited by 401
Shimizugawa, T., Ono, M., Shimamura, M., Yoshida, K., Ando, Y., Koishi, R., Ueda, K., Inaba, T., Minekura, H., Kohama, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203215200 · Cited by 339
Yoshida, K., Shimizugawa, T., Ono, M., & Furukawa, H. (2002) · Journal of Lipid Research · doi:10.1194/jlr.c200010-jlr200 · Cited by 317
Formation and Metabolism of Prebeta-Migrating, Lipid-Poor Apolipoprotein A-I
Rye, K.-A., & Barter, P. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000104029.74961.f5 · Cited by 309
D. Kolovou, G., P. Mikhailidis, D., Kovar, J., Lairon, D., G. Nordestgaard, B., Chye Ooi, T., Perez-Martinez, P., Bilianou, H., Anagnostopoulou, K., & Panotopoulos, G. (2011) · Current Vascular Pharmacology · doi:10.2174/157016111795495549 · Cited by 306
Shimamura, M., Matsuda, M., Yasumo, H., Okazaki, M., Fujimoto, K., Kono, K., Shimizugawa, T., Ando, Y., Koishi, R., Kohama, T., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000252827.51626.89 · Cited by 297
Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease
Rosenson, R. S., Davidson, M. H., Hirsh, B. J., Kathiresan, S., & Gaudet, D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.09.042 · Cited by 260
Cohn, J. S., Johnson, E. J., Millar, J. S., Cohn, S. D., Milne, R. W., Marcel, Y. L., Russell, R. M., & Schaefer, E. J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)35345-1 · Cited by 248
Jackson, K. G., Poppitt, S. D., & Minihane, A. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.08.012 · Cited by 246
Gusarova, V., Alexa, C. A., Wang, Y., Rafique, A., Kim, J. H., Buckler, D., Mintah, I. J., Shihanian, L. M., Cohen, J. C., Hobbs, H. H., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m054890 · Cited by 210
Protein Region Important for Regulation of Lipid Metabolism in Angiopoietin-like 3 (ANGPTL3)
Ono, M., Shimizugawa, T., Shimamura, M., Yoshida, K., Noji-Sakikawa, C., Ando, Y., Koishi, R., & Furukawa, H. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302861200 · Cited by 195
Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion
Wang, Y., Gusarova, V., Banfi, S., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m054882 · Cited by 189
Regulation of triglyceride metabolism by Angiopoietin-like proteins
Mattijssen, F., & Kersten, S. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.10.010 · Cited by 180
Minicocci, I., Montali, A., Robciuc, M. R., Quagliarini, F., Censi, V., Labbadia, G., Gabiati, C., Pigna, G., Sepe, M. L., Pannozzo, F., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1298 · Cited by 168
Self-citationRobciuc, M. R., Maranghi, M., Lahikainen, A., Rader, D., Bensadoun, A., Öörni, K., Metso, J., Minicocci, I., Ciociola, E., Ceci, F., et al. (2013) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.113.301397 · Cited by 163
Self-citationImproved estimation of cholesteryl ester transfer/exchange activity in serum or plasma.
Groener, J. E., Pelton, R. W., & Kostner, G. M. (1986) · Clinical Chemistry · doi:10.1093/clinchem/32.2.283 · Cited by 162
Methodology for studying postprandial lipid metabolism
Lairon, D., Lopez-Miranda, J., & Williams, C. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602749 · Cited by 158
Angiopoietin-like Protein 3 Mediates Hypertriglyceridemia Induced by the Liver X Receptor
Inaba, T., Matsuda, M., Shimamura, M., Takei, N., Terasaka, N., Ando, Y., Yasumo, H., Koishi, R., Makishima, M., & Shimomura, I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213202200 · Cited by 139
Differential regulation and properties of angiopoietin-like proteins 3 and 4
Ge, H., Cha, J.-Y., Gopal, H., Harp, C., Yu, X., Repa, J. J., & Li, C. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500005-jlr200 · Cited by 135
Hepatic ANGPTL3 regulates adipose tissue energy homeostasis
Wang, Y., McNutt, M. C., Banfi, S., Levin, M. G., Holland, W. L., Gusarova, V., Gromada, J., Cohen, J. C., & Hobbs, H. H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515374112 · Cited by 134
Angiopoietin-like protein 3, a hepatic secretory factor, activates lipolysis in adipocytes
Shimamura, M., Matsuda, M., Kobayashi, S., Ando, Y., Ono, M., Koishi, R., Furukawa, H., Makishima, M., & Shimomura, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)03058-9 · Cited by 117
HDL Biogenesis, Remodeling, and Catabolism
Zannis, V. I., Fotakis, P., Koukos, G., Kardassis, D., Ehnholm, C., Jauhiainen, M., & Chroni, A. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-319-09665-0_2 · Cited by 110
Self-citationDeRuyter, M. G., & De Leenheer, A. P. (1978) · Clinical Chemistry · doi:10.1093/clinchem/24.11.1920 · Cited by 106
Dietary determinants of serum paraoxonase activity in healthy humans
Kleemola, P., Freese, R., Jauhiainen, M., Pahlman, R., Alfthan, G., & Mutanen, M. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00594-9 · Cited by 101
Self-citationBarrows, B. R., Timlin, M. T., & Parks, E. J. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2668 · Cited by 86
ANGPTL3 is increased in both insulin-deficient and -resistant diabetic states
Inukai, K., Nakashima, Y., Watanabe, M., Kurihara, S., Awata, T., Katagiri, H., Oka, Y., & Katayama, S. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.151 · Cited by 82
Arca, M., Montali, A., Valiante, S., Campagna, F., Pigna, G., Paoletti, V., Antonini, R., Barillà, F., Tanzilli, G., Vestri, A., et al. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.049 · Cited by 81
Self-citationRegulation of Angiopoietin-Like Proteins (ANGPTLs) 3 and 8 by Insulin
Nidhina Haridas, P. A., Soronen, J., Sädevirta, S., Mysore, R., Quagliarini, F., Pasternack, A., Metso, J., Perttilä, J., Leivonen, M., Smas, C. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1254 · Cited by 75
Self-citationContribution of Triglyceride-rich Lipoproteins to Plasma Free Fatty Acids
Miles, J., & Nelson, R. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-990273 · Cited by 62
Determination of human plasma phospholipid transfer protein mass and activity
Jauhiainen, M., & Ehnholm, C. (2005) · Methods · doi:10.1016/j.ymeth.2004.11.006 · Cited by 61
Self-citationVikstedt, R., Metso, J., Hakala, J. K., Olkkonen, V. M., Ehnholm, C., & Jauhiainen, M. (2007) · Biochemistry · doi:10.1021/bi700833h · Cited by 58
Self-citationMeijssen, S., Cabezas, M. C., Twickler, T. B., Jansen, H., & Erkelens, D. W. (2000) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32015-0 · Cited by 53
Calculation of energy expenditure from indirect calorimetry: assessment of the Weir equation.
Cunningham, J. J. (1990) · PubMed · Cited by 52
Acetoacetate and 3-hydroxybutyrate kinetics in obese and insulin-dependent diabetic humans
Nosadini, R., Avogaro, A., Trevisan, R., Duner, E., Marescotti, C., Iori, E., Cobelli, C., & Toffolo, G. (1985) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1985.248.5.r611 · Cited by 44
Matikainen, N., Adiels, M., Söderlund, S., Stennabb, S., Ahola, T., Hakkarainen, A., Borén, J., & Taskinen, M. (2014) · Obesity · doi:10.1002/oby.20781 · Cited by 42
Tikka, A., Soronen, J., Laurila, P.-P., Metso, J., Ehnholm, C., & Jauhiainen, M. (2014) · Bioscience Reports · doi:10.1042/bsr20140115 · Cited by 39
Self-citationThe angiopoietin-like protein 3: a hepatokine with expanding role in metabolism
Arca, M., Minicocci, I., & Maranghi, M. (2013) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283630cf0 · Cited by 37
Self-citationMinicocci, I., Prisco, C., Montali, A., Costanzo, A. D., Ceci, F., Pigna, G., & Arca, M. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.036 · Cited by 22
Self-citationAlterations of intestinal lipoprotein metabolism in diabetes mellitus and metabolic syndrome
Arca, M. (2015) · Atherosclerosis Supplements · doi:10.1016/s1567-5688(15)50004-4 · Cited by 17
Self-citationDemacker, P. N. M., Hectors, M. P. C., & Stalenhoef, A. F. H. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00326-3 · Cited by 10
Cited by
Ginsberg, H. N., Packard, C. J., Chapman, M. J., Borén, J., Aguilar-Salinas, C. A., Averna, M., Ference, B. A., Gaudet, D., Hegele, R. A., Kersten, S., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab551 · Cited by 979
“32,64,65 Which factors regulate the generation and clearance of chylomicron and very low-density lipoprotein remnants?”
BackgroundMetabolic-associated fatty liver disease and lipoprotein metabolism
Heeren, J., & Scheja, L. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101238 · Cited by 646
“Angiopoietin-like proteins Three members of the angiopoietin-like (ANGPTL) family, ANGPTL3, ANGPTL4 and ANGPTL8, regulate peripheral TRL processing.”
BackgroundInfluentialClinical review on triglycerides
Laufs, U., Parhofer, K. G., Ginsberg, H. N., & Hegele, R. A. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz785 · Cited by 544
ANGPTL3 deficiency and protection against coronary artery disease
Stitziel, N. O., Khera, A. V., Wang, X., Bierhals, A. J., Vourakis, A. C., Sperry, A. E., Natarajan, P., Klarin, D., Emdin, C. A., Zekavat, S. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.02.030 · Cited by 467
“Studies in both mice and humans have demonstrated ANGPTL3 to be a potent inhibitor of LPL, particularly in the post-prandial state (41).”
BackgroundBeyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
Funcke, J.-B., & Scherer, P. E. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r094060 · Cited by 327
Metadata
- Authors
- Minicocci, I., Tikka, A., Poggiogalle, E., Metso, J., Montali, A., Ceci, F., Labbadia, G., Fontana, M., Di Costanzo, A., Maranghi, M., Rosano, A., Ehnholm, C., Donini, L. M., Jauhiainen, M., & Arca, M.
- Affiliations
- Sapienza University of Rome (IT)
- Finnish Institute for Health and Welfare (FI)
- Istituto per lo Sviluppo della Formazione Professionale dei Lavoratori (IT)
- Corresponding author
- Arca, Marcello
- ORCID
- Venue
- Journal of Lipid Research
- Publisher
- Elsevier BV
- Published
- 2016-06
- Volume
- 57
- Issue
- 6
- Pages
- 1097-1107
- ISSN
- 0022-2275 (ISSN-L)
- PMC
- PMC4878193
- OpenAlex
- W2326075804
- Cited by
- 56
- References
- 53
- Citations by year
- 2026: 3 · 2025: 5 · 2023: 3 · 2022: 8 · 2021: 11 · 2020: 4 · 2019: 7 · 2018: 5 · 2017: 8 · 2016: 2
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 1620 d)
- Locations
- Journal of Lipid Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- Sapienza University of Rome (Progetto Ateneo 2006, Progetto Ateneo 2011)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- ANGPTL3, postprandial lipemia, postprandial lipid metabolism, lipoprotein metabolism, triglyceride-rich lipoproteins, apolipoprotein B-48, free fatty acids, hepatic fatty acid oxidation, beta-hydroxybutyrate, high-fat meal, lipoprotein catabolism
- MeSH terms
- Angiopoietin-like Proteins, Angiopoietin-Like Protein 3, Fatty Acids, Nonesterified, Female, Heterozygote, Homozygote, Humans, Hypobetalipoproteinemias, Lipids, Lipoproteins, Male, Middle Aged, Mutation, Triglycerides, Postprandial Period, Angiopoietins, Apolipoprotein B-48
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.